Mouse/human chimeric IgG1 and IgG4 antibodies directed to the house dust mite allergen Der p 2: Use in quantification of allergen specific IgG

Clinical and Experimental Allergy

Volumn 27, Issue 9, 1997, Pages 1095-1102

  Schuurman, J ^a   Perdok, G J ^a   Mueller, G A ^b   Benjamin, D C ^b   Yong Tan, K ^c   Chapman, M D ^a   Aalberse, R C ^a,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF VIRGINIA   (United States)

^c Schieland Hospital   (Netherlands)

^d CENTRAL LABORATORY   (Netherlands)

Author keywords

Chimeric antibody; Der p 2; House dust mite; IgE; IgG1; IgG4; Immunotherapy; RAST; Reversed RAST

Indexed keywords

HOUSE DUST ALLERGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; HOUSE DUST ALLERGY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOGLOBULIN STRUCTURE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RADIOALLERGOSORBENT TEST;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, DERMATOPHAGOIDES; CELL LINE; DUST; GLYCOPROTEINS; HUMANS; HYBRIDOMAS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOTHERAPY; MICE; MITES; RADIOALLERGOSORBENT TEST; RECOMBINANT FUSION PROTEINS;

EID: 0030840479     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb01262.x     Document Type: Article

References (40)

1. Van der Giessen M, Homan WL, Van Kernebeek G, Aalberse RC, Dieges PH. Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy. Int Arch Allergy Appl Immunol 1976; 50:625-40.
2. Devey ME, Wilson DV, Wheeler AW. The IgG subclasses of antibodies to grass pollen allergens produced in hay fever patients during hyposensitization. Clin Allergy 1976; 6:227-36.
3. Aalberse RC, Van der Gaag R, Van Leeuwen J. Serological aspects of IgG4 antibodies I. Prolonged immunization results in an IgG4-restricted response. J Immunol 1983; 130: 722-6.
4. Djurup R. The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen specific immunotherapy. Allergy 1985; 40:469-86.
5. Vijay HM, Perelmutter L. Inhibition of reagin-mediated PCA reactions in monkeys and histamine release from human leukocytes by human IgG4 subclass. Int Arch Allergy Appl Immunol 1977; 53:78-87.
6. Pagan DL, Slaughter CA, Capra JD, Sullivan TJ. Monoclonal antibodies to immunoglobulin G4 induce histamine release from human basophils in vitro. J Allergy Clin Immunol 1982; 70:399-404.
7. Jimeno L, Lombardero M, Carreira J, Moscoso del Prado J. Presence of IgG4 on the membrane of human basophils. Histamine release is induced by monoclonal antibodies directed against the Fab but not the Fc region of the IgG4 molecule. Clin Exp Allergy 1992; 22:1007-14.
8. Van Toorenenbergen AW, Aalberse RC. IgG4 and passive sensitization of basophil leukocytes. Int Arch Allergy Appl Immunol 1981; 65:432-40.
9. Lichtenstein LM, Holtzman NA, Burnett LS. A quantitative in vitro study of the Chromatographic distribution and immunoglobulin characteristics of human blocking antibody. J Immunol 1968; 101:317-24.
10. May CD, Lyman MS, Alberto R, Aduna N. On the measurement of blocking antibody. J Allergy Clin Immunol 1972; 49:54-8.
11. Schumacher MJ, Jeffery SE. Effect of quantity and quality of IgG antibodies on blocking of allergenic histamine release in vitro. Int Arch Allergy Appl Immunol 1979; 58:38-43.
12. Clinton PM, Kemeny DM, Youlten LJF, Lessof MH. Histamine release from peripheral blood leukocytes with purified bee venom allergens: effect of hyperimmune beekeeper plasma. Int Arch Allergy Appl Immunol 1989; 89:43-8.
13. Lambin P, Bouzoumou A, Murrieta M et al. Purification of human IgG4 subclass with allergen-specific blocking activity. J Immunol Methods 1993; 165:99-111.
14. Van Ree R, Aalberse RC. Rabbit IgG directed to a synthetic C-terminal peptide of the major grass pollen allergen Loi p l inhibits human basophil histamine release induced by natural Loi p l. Int Arch Allergy Immunol 1995; 106:250-7.
15. Van Metre TE, Marsh DG, Adkinson NF et al. Immunotherapy decreases skin sensitivity to cat extract. J Allergy Clin Immunol 1989; 83:888-99.
16. Hedlin G, Graff-Lonnevig V, Heilborn H et al. Immunotherapy with cat- and dog-dander extracts. J Allergy Clin Immunol 1991; 87:955-64.
17. Witteman AM, Stapel SO, Sjamsoedin DHS et al. Fel d 1-specific IgG antibodies induced by natural exposure have blocking activity in skin tests. Int Arch Allergy Immunol 1996; 109:369-75.
18. Lessof MH, Sobotka AK, Lichtenstein LM. Protection against anaphylaxis in Hymenoptera-sensitive patients by passive immunization. Monogr Allergy 1977; 12:253-6.
19. Oehling A, Sanz ML, Garcia BE. Immunological parameters in the immunotherapy follow-up. Int Arch Allergy Immunol 1992; 99:474-7.
20. Golden DBK, Meyers DA, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy. J Allergy Clin Immunol 1982; 69:489-93.
21. Aalberse RC, Van Milligen F, Tan KY, Stapel SO. Allergenspecific IgG4 in atopic disease. Allergy 1993; 48:559-69.
22. Kemeny DM, Lessof MH. Immunotherapy in insect venom allergy. In: Allergy: An International Textbook, edited by Lessof MH, Lee TH and Kemeny DM. London, UK. John Wiley & Sons Ltd, 1987, pp. 631-639.
23. Schuurman J, Lourens TE, Perdok GJ, Parren PWHI, Aalberse RC. Mouse/human chimeric IgE antibodies directed to the house dust mite allergen Der p 2. Int Arch Allergy Immunol 1995; 107:465-6.
24. Schuurman J, Perdok GJ, Lourens TE et al. The production of a mouse/human chimeric IgE monoclonal antibody to the house dust mite allergen Der p 2 and its use for the absolute quantification of allergen specific IgE. J Allergy Clin Immunol 1997; 99:545-50.
25. Lind P. Purification and partial characterization of two major allergens from the house dust mite Dermatophagoides pteronyssinus. J Allergy Clin Immunol 1985; 76:753-61.
26. Ovsyannikova IG, Vailes LD, Li Y, Heymann PW, Chapman MD. Monoclonal antibodies to group II Dermatophagoides spp. allergens: murine immune response, epitope analysis, and development of a two-site ELISA. J Allergy Clin Immunol 1994; 94:537-46.
27. Brakenhoff JPJ, De Groot ER, Evers RF, Pannekoek H, Aarden LA. Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J Immunol 1987; 139:4116-21.
28. Neuberger MS, Williams GT, Mitchell EB et al. A haptenspeeific chimaeric IgE antibody with human physiological effector function. Nature 1985; 314:268-70.
29. Brüggemann M, Williams GT, Bindon CI et al. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med 1987; 166: 1351-61.
30. Parren PWHI, Geerts MEJ, Boeije LCM, Aarden LA. Induction of T-cell proliferation by recombinant mouse and chimeric mouse/human anti-CD3 monoclonal antibodies. Res Immunol 1991; 142:749-63.
31. Orlandi R, Guessow DH, Jones PT, Winter G. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86:3833-7.
32. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, a laboratory manual. Cold Spring Harbor Laboratory Press NY, 1989.
33. Takahashi N, Ueda S, Obata M et al. Structure of human immunoglobulin gamma genes: implications for evolution of a gene family. Cell 1982; 29:671-9.
34. Boot JHA, Parren PWHI, Geerts MEJ, Aarden LA. Spontaneous generation of antibody isotype heterogeneity during long-term cultivation of hybridoma cells, Amsterdam: PhD thesis. University of Amsterdam, 1989, pp. 47-58.
35. Boot JHA, Geerts MEJ, De Groot ER, Aarden LA. Murine monoclonal isotype switch variants. Detection with rat monoclonal antibodies in ELISA and isolation by sequential sublining. J Immunol Methods 1988; 106:195-202.
36. Southern PJ, Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promotor. J Mol Appl Genet 1982; 1:327-41.
37. Mueller GA, Hakkaart GAJ. Aalberse RC et al. Characterization of the major house dust mite allergen Der p 2 expressed in E. coli. Manuscript in preparation.
38. Van der Zee JS, Van Swieten P, Jansen HM, Aalberse RC. Skin tests and histamine release with PI-depleted D. pteronyssinus body extracts and purified PI. J Allergy Clin Immunol 1988; 81:884-96.
39. Aalberse RC, Koshte V, Clemens JGJ. Immunoglobulin E antibodies that crossreact with vegetable foods, pollen, and Hymenoptera venom. J Allergy Clin Immunol 1981; 68:356-64.
40. Calkhoven PG, Aalbers M, Koshte VL et al. Relationship between IgG1 and IgG4 antibodies to foods and the development of IgE antibodies to inhalent allergens. I. Establishment of a scoring system for the overall food responsiveness and its application to 213 unselected children. Clin Exp Allergy 1991; 21:91-8.